Abstract
Due to patient noncompliance, we instituted a novel schedule for tandem and ovoids (T&O) insertion and HDR brachytherapy treatment of cervical cancer in 2004. This consisted of delivery of two fractions in two consecutive days, with an intervening inpatient hospital stay. The procedure is repeated 1-2 weeks later. This schedule reduces the number of visits when administering HDR. We now report outcomes of our experience with this dose-fractionation scheme.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
